Taken together, our findings provide new evidence demonstrating that the depleted PGM5‐AS1 competitively binds to miR‐140‐5p, resulting in the decreased expression of FBN1 and suppressed osteosarcoma progression (Fig. 9). This evidence concerns the gene FBN1 and osteosarcoma.